Zhang X, Wang M, Feng B, Zhang Q, Tong J, Wang M
Int J Mol Sci. 2022; 23(10).
PMID: 35628400
PMC: 9144763.
DOI: 10.3390/ijms23105586.
Biswas A, Krishnan P, Amirabadi A, Blaser S, Mercimek-Andrews S, Shroff M
AJNR Am J Neuroradiol. 2020; 41(10):1930-1936.
PMID: 32855186
PMC: 7661073.
DOI: 10.3174/ajnr.A6726.
Lange J, Haslett L, Lloyd-Evans E, Pocock J, Sands M, Williams B
Acta Neuropathol Commun. 2018; 6(1):74.
PMID: 30089511
PMC: 6081811.
DOI: 10.1186/s40478-018-0575-4.
Shyng C, Macauley S, Dearborn J, Sands M
JIMD Rep. 2017; 36:85-92.
PMID: 28213849
PMC: 5680291.
DOI: 10.1007/8904_2017_1.
Tikka S, Monogioudi E, Gotsopoulos A, Soliymani R, Pezzini F, Scifo E
Neuromolecular Med. 2015; 18(1):109-33.
PMID: 26707855
DOI: 10.1007/s12017-015-8382-6.
The novel Cln1(R151X) mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapy.
Miller J, Kovacs A, Pearce D
Hum Mol Genet. 2014; 24(1):185-96.
PMID: 25205113
PMC: 4326326.
DOI: 10.1093/hmg/ddu428.
Classification and natural history of the neuronal ceroid lipofuscinoses.
Mink J, Augustine E, Adams H, Marshall F, Kwon J
J Child Neurol. 2013; 28(9):1101-5.
PMID: 23838030
PMC: 3979348.
DOI: 10.1177/0883073813494268.
Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease).
Hawkins-Salsbury J, Cooper J, Sands M
Biochim Biophys Acta. 2013; 1832(11):1906-9.
PMID: 23747979
PMC: 4573397.
DOI: 10.1016/j.bbadis.2013.05.026.
Intravenous high-dose enzyme replacement therapy with recombinant palmitoyl-protein thioesterase reduces visceral lysosomal storage and modestly prolongs survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis.
Hu J, Lu J, Wong A, Hynan L, Birnbaum S, Yilmaz D
Mol Genet Metab. 2012; 107(1-2):213-21.
PMID: 22704978
PMC: 3444630.
DOI: 10.1016/j.ymgme.2012.05.009.
Combination small molecule PPT1 mimetic and CNS-directed gene therapy as a treatment for infantile neuronal ceroid lipofuscinosis.
Roberts M, Macauley S, Wong A, Yilmas D, Hohm S, Cooper J
J Inherit Metab Dis. 2012; 35(5):847-57.
PMID: 22310926
PMC: 4108163.
DOI: 10.1007/s10545-011-9446-x.
The role of attenuated astrocyte activation in infantile neuronal ceroid lipofuscinosis.
Macauley S, Pekny M, Sands M
J Neurosci. 2011; 31(43):15575-85.
PMID: 22031903
PMC: 3218425.
DOI: 10.1523/JNEUROSCI.3579-11.2011.
Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease.
Kielar C, Wishart T, Palmer A, Dihanich S, Wong A, Macauley S
Hum Mol Genet. 2009; 18(21):4066-80.
PMID: 19640925
PMC: 2758138.
DOI: 10.1093/hmg/ddp355.
Cerebellar pathology and motor deficits in the palmitoyl protein thioesterase 1-deficient mouse.
Macauley S, Wozniak D, Kielar C, Tan Y, Cooper J, Sands M
Exp Neurol. 2009; 217(1):124-35.
PMID: 19416667
PMC: 2679857.
DOI: 10.1016/j.expneurol.2009.01.022.
Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis.
Kielar C, Maddox L, Bible E, Pontikis C, Macauley S, Griffey M
Neurobiol Dis. 2006; 25(1):150-62.
PMID: 17046272
PMC: 1866219.
DOI: 10.1016/j.nbd.2006.09.001.
Inefficient cleavage of palmitoyl-protein thioesterase (PPT) substrates by aminothiols: implications for treatment of infantile neuronal ceroid lipofuscinosis.
Lu J, Hofmann S
J Inherit Metab Dis. 2006; 29(1):119-26.
PMID: 16601878
DOI: 10.1007/s10545-006-0225-z.
Palmitoyl-protein thioesterase 1 deficiency in Drosophila melanogaster causes accumulation of abnormal storage material and reduced life span.
Hickey A, Chotkowski H, Singh N, Ault J, Korey C, MacDonald M
Genetics. 2006; 172(4):2379-90.
PMID: 16452138
PMC: 1456391.
DOI: 10.1534/genetics.105.053306.
Hippocampal pathology in the human neuronal ceroid-lipofuscinoses: distinct patterns of storage deposition, neurodegeneration and glial activation.
Tyynela J, Cooper J, Khan M, Shemilts S, Haltia M
Brain Pathol. 2004; 14(4):349-57.
PMID: 15605981
PMC: 8095893.
DOI: 10.1111/j.1750-3639.2004.tb00077.x.
Selectivity and types of cell death in the neuronal ceroid lipofuscinoses.
Mitchison H, Lim M, Cooper J
Brain Pathol. 2004; 14(1):86-96.
PMID: 14997941
PMC: 8095993.
DOI: 10.1111/j.1750-3639.2004.tb00502.x.
A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease.
Kim Y, Ramirez-Montealegre D, Pearce D
Proc Natl Acad Sci U S A. 2003; 100(26):15458-62.
PMID: 14660799
PMC: 307589.
DOI: 10.1073/pnas.2136651100.
The Finnish Disease Heritage III: the individual diseases.
Norio R
Hum Genet. 2003; 112(5-6):470-526.
PMID: 12627297
DOI: 10.1007/s00439-002-0877-1.
